Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance

Xiaopeng Li,Xiujuan Zhang,Jialin Xia,Linqi Zhang,Bo Chen,Guan Lian,Chuyu Yun,Juan Yang,Yu Yan,Pengcheng Wang,Xuemei Wang,Bo Liu,Huiying Liu,Hui Liang,Yanli Pang,Xian Wang,Changtao Jiang

DOI: https://doi.org/10.1016/j.celrep.2021.109607

IF: 8.8

2021-08-01

Cell Reports

Abstract:The interrelation between hypoxia and immune response has pivotal roles in the pathogenesis of chronic metabolic diseases. However, the role of macrophage HIF-2α in NLRP3 inflammasome activation remains unclear. Here, we show that deficiency of HIF-2α in macrophages results in excessive activation of the NLRP3 inflammasome in a manner dependent on CPT1A-mediated enhancement of fatty acid oxidation (FAO). Mechanistically, HIF-2α binds directly to the Cpt1a promoter and is involved in the regulation of H3K27me3 methylation during NLRP3 inflammasome activation. Myeloid-specific Hif2α knockout mice exhibit exacerbated insulin resistance and increased activation of NLRP3 inflammasome in macrophages. Overexpression of the Hif2α gene or stabilization of the protein by FG-4592 ameliorates insulin resistance and reduces NLRP3 inflammasome activation in macrophages. Taken together, our results suggest that macrophage HIF-2α inhibits FAO-mediated activation of the NLRP3 inflammasome and alleviates insulin resistance.

cell biology